Dev

Studies on the senescent human noradrenergic system with the novel iDISCO 3D immuno-imaging method with special attention on Alzheimer’s disease Investments < €500k Sweden 2016    

TRANSLATIONAL STUDIES OF SAPOSIN C AND GPR37 IN PARKINSON´S DISEASE Investments < €500k Sweden 2016    

Sensory Processing in the Parkinsonian Striatal Microcircuit. Investments < €500k Sweden 2016    

Target molecules for neurorestoration in Parkinson’s diseas Investments < €500k Sweden 2016    

From test-tubes, to mice, to human ALS Investments < €500k Sweden 2016    

ALS is caused by strains of SOD1 prions Investments < €500k Sweden 2016    

Development of in vivo gene therapy methods to treat Parkinson’s disease. Investments < €500k Sweden 2016    

Plasticity of basal ganglia astrocytes in Parkinson´s disease and L-DOPA-induced dyskinesia Investments < €500k Sweden 2016    

Role of LXRs in midbrain dopamine neuron development and Parkinson’s disease Investments < €500k Sweden 2016    

Neurochemical changes associated with Parkinson´s disease and L-Dopainduced dyskinesia Investments < €500k Sweden 2016